| Mr Nagarajan Mohan, | |
|
125 Central Ave, Suite A, Oxford, AL 36203-1847 | |
| (256) 832-2271 | |
| Not Available |
| Full Name | Mr Nagarajan Mohan |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 125 Central Ave, Oxford, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780080135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PTH7186 (Alabama) | Primary |
| 225100000X | Physical Therapist | 40QAO1571300 (New Jersey) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Nagarajan Mohan, 125 Central Ave, Suite A, Oxford, AL 36203-1847 Ph: (256) 832-2271 | Mr Nagarajan Mohan, 125 Central Ave, Suite A, Oxford, AL 36203-1847 Ph: (256) 832-2271 |
News Archive
A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.
The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.
The Pulmonary Hypertension Association (PHA), in conjunction with leading pulmonary hypertension specialists, has announced the launch of an educational campaign to raise awareness of the association between pulmonary arterial hypertension (PAH) and stimulant use, particularly methamphetamine use.
The U.S. Food and Drug Administration (FDA) has granted Selzentry (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals.
› Verified 1 days ago
Hartwell Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 424 Marsh Ln, Oxford, AL 36203 Phone: 256-835-9030 Fax: 256-835-9030 | |
Margaret P Wilhoite, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 651 Snow St, Oxford, AL 36203 Phone: 256-241-7500 | |
Chelsea Shaunte Nelson, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 50 Commons Way Ste D, Oxford, AL 36203 Phone: 256-624-9722 Fax: 256-371-6378 | |
David L Wilhoite, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 651 Snow St, Oxford, AL 36203 Phone: 256-241-7500 | |
Rachel Sheri' Haskins, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1130 Hale St, Oxford, AL 36203 Phone: 256-831-0481 | |
Emily Turner, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 50 Commons Way Ste D, Oxford, AL 36203 Phone: 256-624-9722 | |
Steadfast Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 1720 Hamric Dr E Ste 7, Oxford, AL 36203 Phone: 256-208-5600 |